Heslop HE - Search Results

1

Identification of HLA-DP3-restricted peptides from EBNA1 recognized by CD4(+) T cells.

Voo KS, Fu T, Heslop HE, Brenner MK, Rooney CM, Wang RF. Voo KS, et al. Among authors: heslop he. Cancer Res. 2002 Dec 15;62(24):7195-9. Cancer Res. 2002. PMID: 12499257

2

Reconstitution of the T cell receptor alpha beta repertoire in recipients of allogeneic BMT.

Rencher SD, Hanif I, Heslop HE, Turner VE, Brenner MK, Hurwitz JL. Rencher SD, et al. Among authors: heslop he. Bone Marrow Transplant. 1992 Dec;10(6):521-7. Bone Marrow Transplant. 1992. PMID: 1490202

3

Immunotherapy of leukemia.

Brenner MK, Heslop HE. Brenner MK, et al. Among authors: heslop he. Leukemia. 1992;6 Suppl 1:76-9. Leukemia. 1992. PMID: 1548941 Review.

4

Graft-versus-host reactions and bone-marrow transplantation.

Brenner MK, Heslop HE. Brenner MK, et al. Among authors: heslop he. Curr Opin Immunol. 1991 Oct;3(5):752-7. doi: 10.1016/0952-7915(91)90108-d. Curr Opin Immunol. 1991. PMID: 1836732

5

Possible mechanism of action of interferon alpha in chronic B-cell malignancies.

Heslop HE, Brenner MK, Ganeshaguru K, Hoffbrand AV. Heslop HE, et al. Br J Haematol. 1991 Oct;79 Suppl 1:14-6. doi: 10.1111/j.1365-2141.1991.tb08111.x. Br J Haematol. 1991. PMID: 1931702 Review.

6

Graft versus leukaemia effects after marrow transplantation in man.

Brenner MK, Heslop HE. Brenner MK, et al. Among authors: heslop he. Baillieres Clin Haematol. 1991 Jul;4(3):727-49. doi: 10.1016/s0950-3536(09)90010-5. Baillieres Clin Haematol. 1991. PMID: 1958889 Review.

7

Malignant plasma cells are sensitive to LAK cell lysis: pre-clinical and clinical studies of interleukin 2 in the treatment of multiple myeloma.

Gottlieb DJ, Prentice HG, Mehta AB, Galazka AR, Heslop HE, Hoffbrand AV, Brenner MK. Gottlieb DJ, et al. Among authors: heslop he. Br J Haematol. 1990 Aug;75(4):499-505. doi: 10.1111/j.1365-2141.1990.tb07789.x. Br J Haematol. 1990. PMID: 2119792

8

Gamma-interferon and tumor necrosis factor production after bone marrow transplantation is augmented by exposure to marrow fibroblasts infected with cytomegalovirus.

Duncombe AS, Meager A, Prentice HG, Grundy JE, Heslop HE, Hoffbrand AV, Brenner MK. Duncombe AS, et al. Among authors: heslop he. Blood. 1990 Sep 1;76(5):1046-53. Blood. 1990. PMID: 2168224 Free article.

9

Endogenously generated activated killer cells circulate after autologous and allogeneic marrow transplantation but not after chemotherapy.

Reittie JE, Gottlieb D, Heslop HE, Leger O, Drexler HG, Hazlehurst G, Hoffbrand AV, Prentice HG, Brenner MK. Reittie JE, et al. Among authors: heslop he. Blood. 1989 Apr;73(5):1351-8. Blood. 1989. PMID: 2495037 Free article.

10

Tumor necrosis factor mediates autocrine growth inhibition in a chronic leukemia.

Duncombe AS, Heslop HE, Turner M, Meager A, Priest R, Exley T, Brenner MK. Duncombe AS, et al. Among authors: heslop he. J Immunol. 1989 Dec 1;143(11):3828-34. J Immunol. 1989. PMID: 2584719

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

424 results

Search Page

Filters